Australia-based cannabis grower and producer Little Green Pharma (LPG) saw a significant jump in revenue for the quarter ending September 30, 2023, driven by strong growth in European markets, particularly France, where full legalization is expected in 2025. The company’s oil and flower sales increased significantly, highlighting the growing demand for medical cannabis in Europe.